Gary A. Zarkin

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter

Filter by Publication Type

Search Results

Corrigendum to "Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail" [Drug Alcohol Depend. 217 (2020) 108292]: [Drug Alcohol Depend. 217 (2020) 108292]

Corrigendum to "Cost and cost-effectiveness of abstinence contingent wage supplements".: [Drug Alcohol Depend. 244 (2023) 109754]

Modeling the impact of a long-term horizon and multiple treatment episodes on estimates of the cost-effectiveness of alcohol treatment in the United States

Health care use and cost of treatment for adolescents and young adults with opioid use disorder

Establishing a protocol for determining the costs of an integrated set of evidence-based practices aimed at reducing opioid overdose deaths

Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: Study protocol of a randomized controlled trial

Association of living in a food desert and poor periconceptional diet quality in a cohort of nulliparous pregnant individuals

Prescribing of low-dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands

Impact of severe aortic stenosis on quality of life

Estimated reductions in opioid overdose deaths with sustainment of public health interventions in 4 US states

Modeling the impact of a long-term horizon and multiple treatment episodes on the cost-effectiveness of alcohol treatment in the United States

Cost and cost-effectiveness of abstinence contingent wage supplements

Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

More than half of patients with a rheumatic disease or immunologic condition undergoing methotrexate treatment reside in states in which the overturning of Roe v. Wade can jeopardize access to medications with abortifacient potential